Achieving long-term continuous blood naltrexone and 6-β-naltrexol coverage following sequential naltrexone implants

Addiction Biology

Volumn 9, Issue 1, 2004, Pages 67-72

  Hulse, G K ^a   Arnold Reed, D E ^a   O'Neil, G ^a,b   Chan, C T ^b   Hansson, R C ^c  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b Australian Med Procedures Res F   (Australia)

^c Chemistry Centre Western Australia   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

NALTREXOL; NALTREXONE;

ADULT; ARTICLE; AUSTRALIA; BLOOD ANALYSIS; BLOOD SAMPLING; CLINICAL ARTICLE; DRUG BLOOD LEVEL; DRUG IMPLANTATION; FEMALE; FOLLOW UP; HEROIN DEPENDENCE; HUMAN; INFORMATION PROCESSING; MALE; PRIORITY JOURNAL; RELAPSE;

ADULT; BODY MASS INDEX; COHORT STUDIES; DELAYED-ACTION PREPARATIONS; DRUG ADMINISTRATION SCHEDULE; DRUG IMPLANTS; FEMALE; FOLLOW-UP STUDIES; HEROIN DEPENDENCE; HUMANS; MALE; MIDDLE AGED; NALTREXONE; NARCOTIC ANTAGONISTS; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 2342587369     PISSN: 13556215     EISSN: None     Source Type: Journal    
DOI: 10.1080/13556210410001674112     Document Type: Article

References (20)

1. Tennant FS, Rawson RA, Cohen AJ, Mann A. Clinical experience with naltrexone in suburban opioid addicts. J Clin Psychiatry 1984;45:42-5.
2. Anton RE, Hogan I, Jalali B, Riordan CE, Kleber HD. Multiple family therapy and naltrexone in the treatment of opiate-dependence. Drug Alcohol Depend 1981;8:157-68.
3. Azarian A, Papiasvilli A, Joseph H. A study of the use of clonidine and naltrexone in the treatment of opiod addiction in the former USSR. J Addict Dig 1994;13:35-52.
4. Bell JR, Young MR, Masterman SC, et al. A pilot study of naltrexone-accelerated detoxification in opioid dependence. Med J Aust 1999;171:26-30.
5. Hulse GK, Basso MR. The association between naltrexone compliance and daily supervision. Drug Alcohol Rev 2000;19:41-8.
6. San L, Pomarol G, Peri JM, et al. Follow-up after a six-month maintenance period on naltrexone vernis placebo in heroin addicts. Br J Addict 1991;86:983-90.
7. Willette RE. Narcotic antagonists. An alternative for treating opioid dependence. Am Pharm 1982;NS22:44-6.
8. Chiang CN, Hollister LE, Gillespie HK, Foltz RL. Clinical evaluation of a naltrexone sustained-release preparation. Drug Alcohol Depend 1985;16:1-8.
9. Brewer C. Naltrexone implants for opiate addiction: new life for a middle aged drug. Pharm J 2001;267:260.
10. Comer SD, Collins ED, Kleber HD, et al. Depot naltrexone: long-lasting antagonism of the effects of heroin in humans. Psychopharmacology (Berl.) 2002;159:351-60.
11. Chiang CN, Hollister LE, Kishimoto A, Barnett G. Kinetics of a naltrexone sustained-release preparation. Clin Pharmacol Ther 1984;36:704-8.
12. Vereby K. The clinical pharmacology of naltrexone: pharmacology and pharmacodynamics. In: Barnett REWAG, editor. Naltrexone. Research Monograph no. 28. Rockville, MD: National Institute on Drug Abuse, 1980:147-58.
13. Hulse GK, Arnold-Reed DE, O'Neil G, et al. Blood naltrexone and 6-β-naltrexol levels following naltrexone implant: comparing two naltrexone implants. Addict Biol 2004;9:57-63.
14. Brewer C. Serum naltrexone and 6-beta-naltrexol levels from naltrexone implants can block very large amounts of heroin: a report of two cases. Addict Biol 2002;7:321-3.
15. Vereby K, Volavka J, Mule SJ, Resnik RB. Naltrexone: disposition, metabolism and effects after acute and chronic dosing. Clin Pharmacol Ther 1976;20:315-28.
16. Bugge CJL, Grun I, Stanfor K, Tan MS, Garcia DB. Determination of naltrexone and 6-β-naltrexol in human plasma by LC-MS-MS 1996. Available at: http://www.cedracorp.com/naltrex.htm
17. Chiang CN, Kishimoto A, Barnett G, Leo E, Hollister LE. Implantable narcotic antagonists: a possible new treatment for narcotic addiction. Psychopharmacol Bull 1985;21:672-5.
18. Hamilton RJ, Olmedo RE, Shah S, et al. Complications of ultrarapid opioid detoxification with subcutaneous naltrexone pellets. Acad Emerg Med 2002;9:63-8.
19. Ferrari A, Bertolotti M, Dell'Utri A, Avico U, Sternieri E. Serum time course of naltrexone and 6-beta-naltrexol levels during long term treatment in drug addicts. Drug Alcohol Depend 1998;52:211-20.
20. Hulse GK, Arnold-Reed DE, Reece S, Hansson R. Blood naltrexone and 6-β-naltrexol levels following naltrexone implant: a comparison of two brands. Paper presented at the the 7th International Stapleford Conference, Nijmegen, the Netherlands, November 2002.